The study aimed to understand the link between viral infections such as HCMV and neurodegenerative diseases such as Alzheimer’s.

In 2024, UMass Chan celebrated its second Nobel Laureate, opened the new education and research building and launched a regional campus in Burlington.  

Top story: UMass Chan Medical School celebrated the Classes of 2024 of the T.H. Chan School of Medicine, Tan Chingfen Graduate School of Nursing and the Morningside Graduate School of Biomedical Sciences on Sunday, June 2.

Top story: Leadership, health systems science and interprofessional education at the core of new regional campus in Burlington 

Top story: U.S. News & World Report 2024 rankings of America’s Best Grad Schools place UMass Chan in the top tier of medical schools across the nation for primary care education.  

Top story: UMass Chan leaders and invited dignitaries cut the ribbon on the new education and research building, as WHO Director-General Tedros Adhanom Ghebreyesus, PhD, received an honorary degree and delivered the keynote address. 

Top story: UMass Chan Medical School researcher Victor R. Ambros, PhD, will share the 2024 Nobel Prize in Physiology or Medicine for his co-discovery of microRNA, the very short, single-stranded RNA molecules that are now understood to play a critical role in post-transcriptional gene regulation.

The student inductees to the Alpha Omega Alpha honor society were lauded for dedication to vulnerable populations, curriculum development and climate change.  

ImmVue Therapeutics Inc. has exclusively licensed allosteric small molecule compounds identified in the laboratory of Joonsoo Kang, PhD, professor of pathology at UMass Chan Medical School, for clinical development as a potential cancer therapeutic.

Jennifer Adair, PhD, will join UMass Chan as associate director of the Horae Gene Therapy Center vice chair of the Department of Genetic & Cellular Medicine.